New York State to Issue 1445 New Cannabis Licenses

Regulations by 2FIRSTS.ai
Dec.27.2023
New York State to Issue 1445 New Cannabis Licenses
New York State plans to issue up to 1,445 new cannabis licenses in the coming weeks to boost the legal marijuana industry.

According to a recent report by American local media elespanol, the state of New York in the United States is set to issue up to 1445 new cannabis business licenses in the coming weeks, aiming to boost the growth of the legal marijuana industry.

 

According to local media reports, these licenses will be issued to retailers, as well as to manufacturers or small-scale businesses, as bureaucratic and legal issues have arisen after the legalization of recreational marijuana in the state in 2021, making it difficult for them to enter the market.

 

By the end of 2022, the first legal recreational marijuana store in New York opened its doors. Since then, only 40 stores in the entire state have remained operational, falling far short of the government's initial goal of having at least 150 stores in operation by the end of this year.

 

Many legal marijuana dispensaries are unable to compete with the illegal marijuana market, which sometimes operates almost indistinguishably from licensed businesses.

 

The authorities are hoping to prioritize businesses that have already leased or own premises for the new license. The issuance of the new license is expected to commence in January or February.

 

In November 2022, The New York Times reported on the situation of over 270,000 kilograms of marijuana being stuck in warehouses due to delays in the opening of legal cannabis stores.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Imperial Tobacco Canada: Ban on ZONNIC Nicotine Pouches in Convenience Stores Leads to Cigarette Sales Rebound, Calls for Restoring Multi-Channel Supply
Imperial Tobacco Canada: Ban on ZONNIC Nicotine Pouches in Convenience Stores Leads to Cigarette Sales Rebound, Calls for Restoring Multi-Channel Supply
Imperial Tobacco Canada stated that one year ago, the government removed the nicotine pouch ZONNIC from convenience stores, restricting sales to behind-the-counter in pharmacies. This move caused ZONNIC sales to plummet, cigarette sales to rebound by 2.8%, and was accompanied by a surge of high-dose illegal nicotine pouches and black-market cigarettes (exceeding 500 million packs annually). The company is calling for an evidence-based harm reduction approach to restore multi-channel supply throu
Aug.20 by 2FIRSTS.ai
Experts to Debate Regional THR at first Asia Forum on Nicotine
Experts to Debate Regional THR at first Asia Forum on Nicotine
The first Asia Forum on Nicotine will be held on August 27, 2025, focusing on tobacco harm reduction in Asia. Experts will discuss regulation, scientific evidence, and clinical practice to promote cross-border dialogue and cooperation.
Aug.12
UK MHRA Releases Database with 329 e-cigarette SKUs, Including Brands like ELFBAR, SKE, OXVA, and INNOKIN
UK MHRA Releases Database with 329 e-cigarette SKUs, Including Brands like ELFBAR, SKE, OXVA, and INNOKIN
The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK announced 329 SKUs in its e-cigarette product notification database between August 2 and August 10, including updates on rechargeable e-cigarettes, open-system e-cigarettes, and multi-flavor pods from brands such as ELFBAR, OXVA, INNOKIN, SKE, and VAPES BARS.
Aug.11 by 2FIRSTS.ai
Vaping and the Environment: A Call for Responsible Harm Reduction
Vaping and the Environment: A Call for Responsible Harm Reduction
Tobacco harm reduction expert Lindsey Stroud examines the environmental impact of vape waste, citing global research from Circular Vape Recycle. She highlights the risks of plastics, lithium batteries, and nicotine pollution, and stresses that education, recycling programs, and manufacturer responsibility are key alternatives to bans, enabling environmental protection and harm reduction to progress together.
Aug.15 by 2FIRSTS.ai
2Firsts Exclusive with ARAC: What Juul’s FDA Approval Reveals About U.S. Tobacco Regulation
2Firsts Exclusive with ARAC: What Juul’s FDA Approval Reveals About U.S. Tobacco Regulation
2Firsts spoke with the leadership team at ARAC to analyze the regulatory context and industry implications of the FDA’s approval of five Juul products. ARAC noted that the decision highlights FDA’s increasing emphasis on real-world switching behavior as a key criterion for authorization. While more MGOs may follow, companies must meet rigorous standards in toxicology, manufacturing, and population-level risk assessments.
Jul.21
Legal Commentary: FDA Approves JUUL Menthol E-Cigarettes and Releases Key Scientific Evaluation Criteria
Legal Commentary: FDA Approves JUUL Menthol E-Cigarettes and Releases Key Scientific Evaluation Criteria
2Firsts received a legal commentary from lawyer Zheng Mingwei’s team, analyzing the FDA’s approval of JUUL menthol e-cigarettes. The article outlines key scientific data, regulatory standards, and industry implications.
Jul.22